StockCIK 1579428

Axsome Therapeutics, Inc. (AXSM): Insider Trades and Fund Holdings

In the past 12 months, Axsome Therapeutics, Inc. insiders reported 0 open-market purchases worth $0 and 1 sale worth $2.09M; 1 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$2.09MSold by insiders, 12 months

2Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 3, 2026.

Recent AXSM insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 3	Sep 3	Mark L. JacobsonCOO	COO	▼ SELL10b5-1	10,000	208.65	$2.09M	All sold	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Mark L. Jacobson	COO	0	$0	1	$2.09M	Sep 3, 2026

Tracked funds that report AXSM

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	262,000	$64.1M	0.09%	▲ +59.5%
Bridgewater Associates	Q2 2026	58,217	$14.2M	0.06%	▲ +2.2%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →